Roche devotes some R&D to manufacturing; UPS starts door-to-door cold chain in Asia;

> At Roche's newly opened R&D center in Switzerland, some researchers will focus on such manufacturing processes as processing new active ingredients into tablets, capsules and injectable dosage forms in vials and pre-filled syringes. News

> UPS ($UPS) has launched Temperature True, a door-to-door cold chain transportation and monitoring service in Asia, and PharmaPort 360, an airfreight container for healthcare cold chain transportation. Story

> Photonz has transferred its strain and fermentation process for producing the omega-3 fatty acid, eicosapentaenoic acid (EPA), to a contract manufacturer, moving a step closer to commercial manufacturing by fermentation. Report

> DHL Global Forwarding has signed a master lease agreement with container provider CSafe, broadening its offerings for temperature-controlled shipments. DHL release

> BioMarin Pharmaceutical ($BMRN) will double the capacity of its Novato, CA, plant to produce $1 billion in products, including its biggest seller Naglazyme. Item

> Despite preliminary interest from such big-name shippers as FedEx ($FDX) and DHL, Hyderabad is not likely to become the much-needed cargo hub for Indian drugs and other products because of its location and lack of manufacturing base, says an unnamed analyst. Story

> Novavax ($NVAX) plans a doubling of production capacity with its planned move to Gaithersburg, MD, to better handle a recent $179 million federal contract to develop seasonal and pandemic flu vaccines. Story

> Six drug-delivery technologies are helping drugmakers extend patents: affinity-based targeting, controlled/sustained-release systems, passive delivery, active device delivery, passive device delivery and processing technologies. Release